SE423994B - Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra - Google Patents

Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra

Info

Publication number
SE423994B
SE423994B SE7713721A SE7713721A SE423994B SE 423994 B SE423994 B SE 423994B SE 7713721 A SE7713721 A SE 7713721A SE 7713721 A SE7713721 A SE 7713721A SE 423994 B SE423994 B SE 423994B
Authority
SE
Sweden
Prior art keywords
prolin
therapentic
procedure
preparation
pipecolic acid
Prior art date
Application number
SE7713721A
Other languages
English (en)
Swedish (sv)
Other versions
SE7713721L (sv
Inventor
M A Ondetti
F L Weisenborn
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE7713721L publication Critical patent/SE7713721L/xx
Publication of SE423994B publication Critical patent/SE423994B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7713721A 1976-12-03 1977-12-02 Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra SE423994B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/747,280 US4116962A (en) 1976-12-03 1976-12-03 Pyrrolidine and piperidine-2-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
SE7713721L SE7713721L (sv) 1978-06-04
SE423994B true SE423994B (sv) 1982-06-21

Family

ID=25004419

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713721A SE423994B (sv) 1976-12-03 1977-12-02 Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra

Country Status (33)

Country Link
US (3) US4116962A (ro)
JP (1) JPS5371014A (ro)
AR (1) AR220525A1 (ro)
AT (1) AT362780B (ro)
AU (1) AU513051B2 (ro)
BE (1) BE861453A (ro)
CA (1) CA1080729A (ro)
CH (1) CH634830A5 (ro)
CS (1) CS199514B2 (ro)
DD (1) DD134224A5 (ro)
DE (1) DE2752720A1 (ro)
DK (1) DK539077A (ro)
EG (1) EG12981A (ro)
ES (1) ES464463A1 (ro)
FI (1) FI68221C (ro)
FR (1) FR2372803A1 (ro)
GB (1) GB1591229A (ro)
GR (1) GR72452B (ro)
HK (1) HK8882A (ro)
HU (1) HU176021B (ro)
IE (1) IE46264B1 (ro)
IL (1) IL53292A0 (ro)
IT (1) IT1112112B (ro)
NL (1) NL187163C (ro)
NO (1) NO774125L (ro)
NZ (1) NZ185603A (ro)
PH (2) PH13488A (ro)
PT (1) PT67353B (ro)
RO (1) RO74877A (ro)
SE (1) SE423994B (ro)
SU (1) SU731891A3 (ro)
YU (1) YU283877A (ro)
ZA (1) ZA776508B (ro)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198517A (en) * 1976-12-03 1980-04-15 E. R. Squibb & Sons, Inc. Histidine derivatives
US4116962A (en) * 1976-12-03 1978-09-26 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4284780A (en) * 1977-01-17 1981-08-18 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4284779A (en) * 1977-01-17 1981-08-18 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4241076A (en) * 1978-02-21 1980-12-23 E. R. Squibb & Sons, Inc. Halogenated substituted mercaptoacylamino acids
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
US4179568A (en) * 1978-07-31 1979-12-18 E. R. Squibb & Sons, Inc. (N-lower alkyl-3,5-dioxo-3-pyrrolidinyl)thioalkanoylpyrrolidine-and piperidine-carboxylic acid compounds
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NZ190995A (en) * 1978-09-05 1982-03-09 American Cyanamid Co Substituted omega propionyl or butyryl l-prolines and pharmaceutical compositions
NL7809120A (nl) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw Werkwijze voor de bereiding van proline-derivaten.
US4690939A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
US4690938A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
US4690940A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
GR73585B (ro) * 1978-09-11 1984-03-26 Univ Miami
US4690937A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4698355A (en) * 1979-08-14 1987-10-06 University Of Miami Anti-hypertensive agents
US4698356A (en) * 1979-08-14 1987-10-06 University Of Miami Anti-hypertensive agents
US4695577A (en) * 1979-08-14 1987-09-22 University Of Miami Anti-hypertensive agents
US4311697A (en) * 1978-12-22 1982-01-19 E. R. Squibb & Sons, Inc. Derivatives of mercaptoacyl prolines and pipecolic acids
US4217359A (en) * 1979-01-15 1980-08-12 E. R. Squibb & Sons, Inc. Carbamate derivatives of mercaptoacyl hydroxy prolines
US4297282A (en) * 1979-03-02 1981-10-27 Sumitomo Chemical Company, Limited Resolution of mercaptopropionic acids
US4329473A (en) * 1979-06-01 1982-05-11 Almquist Ronald G Oxoalkanoic acid derivatives as inhibitors of angiotensin converting enzyme
US4549992A (en) * 1979-07-13 1985-10-29 Usv Pharmaceutical Corp. Antihypertensive amides
US4256761A (en) * 1979-07-13 1981-03-17 Usv Pharmaceutical Corporation Antihypertensive amides
US4595675A (en) * 1979-09-19 1986-06-17 Hoechst Aktiengesellschaft Bicyclic α-iminocarboxylic acid compounds having hypotensive activity
US4356182A (en) * 1979-10-22 1982-10-26 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US4330548A (en) * 1980-01-14 1982-05-18 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of keto substituted pipecolic acid
US4296113A (en) * 1980-01-14 1981-10-20 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of keto substituted proline and pipecolic acid
IT1144077B (it) * 1980-01-29 1986-10-29 Sigma Tau Ind Farmaceuti Carnitinammidi di amminoacidi otticamente attivi e procedimento per la loro preparazione
US4321392A (en) * 1980-02-06 1982-03-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-oxazolidine-carboxylic acids
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents
US4734420A (en) * 1980-03-05 1988-03-29 University Of Miami Anti-hypertensive agents
US4690936A (en) * 1980-03-05 1987-09-01 University Of Miami Anti-hypertensive agents
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4299769A (en) * 1980-04-28 1981-11-10 American Cyanamid Company ω-Heteroaroyl(propionyl or butyryl)-L-prolines
US4342690A (en) * 1980-04-28 1982-08-03 American Cyanamid Company ω-Heteroaroyl(propionyl or butyryl)-L-prolines
US4342689A (en) * 1980-04-28 1982-08-03 American Cyanamid Company ω-Heteroaroyl(propionyl or butyryl)-L-prolines
US4342691A (en) * 1980-04-28 1982-08-03 American Cyanamid Company ω-Heteroaroyl(propionyl or butyryl)-L-prolines
US4316905A (en) * 1980-07-01 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of various 4-substituted prolines
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4499287A (en) * 1981-02-02 1985-02-12 E. R. Squibb & Sons, Inc. Certain-4-hydroxy-proline derivatives
US4456761A (en) * 1981-02-02 1984-06-26 E. R. Squibb & Sons, Inc. 4-Substituted dehydroprolines
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4521607A (en) * 1981-02-27 1985-06-04 Takeda Chemical Industries, Ltd. Chromanyl glycines
US4503043A (en) * 1981-12-07 1985-03-05 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids
US4442038A (en) * 1982-09-17 1984-04-10 Norwich Eaton Pharmaceuticals, Inc. Converting enzyme inhibitors
DE3243369A1 (de) 1982-11-24 1984-05-24 Basf Ag, 6700 Ludwigshafen Bis-(benzoylthio)-carbonsaeuren, ihre herstellung und verwendung zur herstellung von wirkstoffen
US5096925A (en) * 1984-06-08 1992-03-17 Ciba-Geigy Corporation N-substituted butyramide derivatives
WO1986000066A1 (en) * 1984-06-08 1986-01-03 Ciba-Geigy Ag N-substituted butyramide derivatives
EP0225292A3 (en) * 1985-12-06 1988-11-30 Ciba-Geigy Ag Certain n-substituted butyramide derivatives
US5166212A (en) * 1985-12-06 1992-11-24 Ciba-Geigy Corporation Certain n-substituted butyramide derivatives
EP0384636A1 (en) * 1989-02-21 1990-08-29 FISONS plc Pharmaceutically active compounds
CA2141739A1 (en) * 1993-05-03 1994-11-10 Alfons M. Verbruggen Method for preparing a metal-radionuclide-labelled protein
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
JP6735518B2 (ja) * 2015-01-06 2020-08-05 国立研究開発法人理化学研究所 新規アンジオテンシン変換酵素阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2714119A (en) * 1953-08-07 1955-07-26 Sterling Drug Inc Process for preparing amides of alphamercapto lower fatty acids
US3510504A (en) * 1965-01-21 1970-05-05 Lilly Co Eli Adamantyloxycarbonyl derivatives of alpha-amino acids
US3624143A (en) * 1968-05-10 1971-11-30 Merck & Co Inc Compounds of the class {62 -aralkylthio-substituted-{60 -amino acids
BE792042A (fr) * 1971-11-30 1973-05-29 Ciba Geigy Procede de preparation de nouvelles alcenylene-amines substituees en 3
US3971828A (en) * 1972-10-03 1976-07-27 Santen Pharmaceutical Co. Ltd. N-(mercaptoacyl)aminoacids
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
US4116962A (en) * 1976-12-03 1978-09-26 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives

Also Published As

Publication number Publication date
IT1112112B (it) 1986-01-13
CA1080729A (en) 1980-07-01
US4154936A (en) 1979-05-15
ZA776508B (en) 1978-08-30
JPS6121225B2 (ro) 1986-05-26
NO774125L (no) 1978-06-06
DE2752720A1 (de) 1978-06-08
GB1591229A (en) 1981-06-17
AU3048577A (en) 1979-05-17
ATA857477A (de) 1980-11-15
YU283877A (en) 1983-01-21
SU731891A3 (ru) 1980-04-30
PH13488A (en) 1980-05-21
NL187163B (nl) 1991-01-16
NL187163C (nl) 1991-06-17
ES464463A1 (es) 1978-09-01
AR220525A1 (es) 1980-11-14
HK8882A (en) 1982-03-05
IE46264B1 (en) 1983-04-20
AU513051B2 (en) 1980-11-13
CS199514B2 (en) 1980-07-31
PH14255A (en) 1981-04-13
IE46264L (en) 1978-06-03
EG12981A (en) 1980-10-31
IL53292A0 (en) 1978-01-31
PT67353B (fr) 1979-05-15
FR2372803B1 (ro) 1981-07-03
FI68221C (fi) 1985-08-12
FI773639A (fi) 1978-06-04
SE7713721L (sv) 1978-06-04
BE861453A (fr) 1978-06-02
US4116962A (en) 1978-09-26
CH634830A5 (de) 1983-02-28
JPS5371014A (en) 1978-06-24
US4140864A (en) 1979-02-20
NL7712612A (nl) 1978-06-06
GR72452B (ro) 1983-11-09
DD134224A5 (de) 1979-02-14
FR2372803A1 (fr) 1978-06-30
PT67353A (fr) 1978-01-01
FI68221B (fi) 1985-04-30
DK539077A (da) 1978-06-04
RO74877A (ro) 1980-10-30
NZ185603A (en) 1982-03-09
AT362780B (de) 1981-06-10
HU176021B (en) 1980-11-28

Similar Documents

Publication Publication Date Title
SE423994B (sv) Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
SE7700051L (sv) Forfarande for framstellning av l-(substituerd amino) alkanoyl-2-(dibesoxazepin-10-karbonyl)hydraziner och derivat derav
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151895C (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO801235L (no) Fremgangsmaate for fremstilling av hydroksyderivater av isopropylaminopyrimidin
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
NO771375L (no) Fremgangsm}te ved fremstilling av derivater av 2-iminothiazolidiner og 2-iminothiazoliner
NO800564L (no) Fremgangsmaate for fremstilling av penicillinderivater
SE406586B (sv) Nytt forfarande for framstellning av 3-fenyl-indol-2-sarbonitril och derivat derav
NO780834L (no) Fremgangsmaate for fremstilling av isobutyramid-derivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7713721-4

Effective date: 19920704

Format of ref document f/p: F